Senior Manager of Analytics, Lyra Health
$134-205k
+ Discretionary restricted stock units may be provided
More information about location
Employee mental health care provider
Job no longer available
Employee mental health care provider
1001+ employees
Job no longer available
$134-205k
+ Discretionary restricted stock units may be provided
More information about location
1001+ employees
Company mission
To transform access to life-changing mental health care.
Jump to section
Company mission
To transform access to life-changing mental health care.
Our take
In the United States, millions of people suffer from mental illness each year - a figure which is unfortunately on the rise - and research suggests that depression and anxiety disorders lead to $1 trillion in lost productivity worldwide each year. Lyra Health is one company out to tackle these issues head-on, by delivering mental health care for employees.
Lyrah Health is seen as a key player alongside other online mental telehealth platforms, which include Calm, Genoa, and Talkspace. The company offers video counselling sessions and one-to-one messaging to help users with a variety of conditions including anxiety, depression, and substance use disorder. Coaching is also offered as a preventative measure.
Lyra Health boasts a 90% satisfaction rate across its more than 2.2 million members, demonstrating the impact that its products can have on wellbeing. In 2022, Lyra announced its acquisition of ICAS World, an international provider of employee assistance programs. Its global network includes over 1,500 companies and 6.3 million users across more than 155 countries, which should give Lyra smooth inroads into global markets.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Monthly tech stipend
- Full access to Lyra’s mental health services for employees and their eligible dependents—at no charge
- Generous compensation, 401k, and equity options
- Medical, dental, and vision benefits, and free monthly membership to One Medical
- Four weeks of vacation and paid holidays
Funding (last 2 of 8 rounds)
Jan 2022
$35m
SERIES F
May 2021
$200m
SERIES F
Total funding: $690.1m
This company has top investors
Leadership
David Ebersman
(Co-Founder & CEO)Former Equity Research Analyst at Oppenheimer & Co. Also served as the CFO at Facebook, and worked at Genentech for 15 years, leaving as Chief Financial Officer & Executive VP.
Articles
Jobs (8)
Software Engineering
Finance, Legal & Compliance
Design
Sales & Account Management